So far I have just found a negative study? esp. the most recent article from American journal of transplantation this year? So is this the end? or is Rituximab good only for sensitized or ABO incompatible? Have you a good profile for it?
There is no data based on evidence based medicine neither in non-sensitized patients
Thank you very much, Prof. Salvadori.
This is very helpful! I appreciated your input to an intraining fellow like myself.
Best regards,
Wisit
Can I suggest the Systematic Review recently published by Macklin et al in Transplantation Reviews. They looked specifically at this population, and in very brief summary the answer is no...
Dear dr O'Callaghan, is the same paper I have already suggested and sent dr. Cheungpasitporn : I think that for dr Cheungpasitporn studies might be interesting this new study I am now encloding,
professor Maurizio Salvadori
Thank you very much, Dr.O'Callaghan and again, Prof. Salvadori. These 2 review papers are very helpful! I understand much better in the use of RTX for both sensitized and non-sensitized settings!
Thanks a million!
Best regards,
Wisit
Please see report below. Rituxamab is effective at preventing an anamnestic response in patients who may appear to be nonsensitized.
Thank you very much, Dr.Philogene!
Very interesting and helpful information that really enlighten my day to read more on anamnestic response.
Thank you very much!
Wisit